PRIORITY RISK FACTORS FOR THE DEVELOPMENT OF DIABETES MELLITUS DURING THE COVID-19 PANDEMIC: A CLINICAL ASSESSMENT

Аннотация

The COVID-19 pandemic has had a profound impact on global health, contributing to a surge in the incidence of non-communicable diseases, particularly diabetes mellitus (DM). SARS-CoV-2, the virus responsible for COVID-19, has been implicated in damaging pancreatic beta cells, which may lead to impaired insulin production and the onset of type 2 diabetes, especially in individuals recovering from severe COVID-19. A growing number of post-COVID-19 cases have shown newly diagnosed diabetes, raising concerns about the virus's role in the development of metabolic disorders.